Moleculin Biotech Inc (MBRX)
2.45
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.43
-0.02
(-0.82%)
After-Hours: 20:00
Moleculin Biotech Enterprise Value: -3.876M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | -3.876M |
| October 31, 2024 | -3.449M |
| October 30, 2024 | -3.62M |
| October 29, 2024 | -3.392M |
| October 28, 2024 | -3.392M |
| October 25, 2024 | -3.520M |
| October 24, 2024 | -3.62M |
| October 23, 2024 | -3.592M |
| October 22, 2024 | -3.592M |
| October 21, 2024 | -3.250M |
| October 18, 2024 | -3.492M |
| October 17, 2024 | -4.132M |
| October 16, 2024 | -3.961M |
| October 15, 2024 | -4.217M |
| October 14, 2024 | -4.104M |
| October 11, 2024 | -3.904M |
| October 10, 2024 | -3.933M |
| October 09, 2024 | -3.592M |
| October 08, 2024 | -3.734M |
| October 07, 2024 | -3.705M |
| October 04, 2024 | -4.132M |
| October 03, 2024 | -3.848M |
| October 02, 2024 | -3.677M |
| October 01, 2024 | -2.909M |
| September 30, 2024 | -2.767M |
| Date | Value |
|---|---|
| September 27, 2024 | -3.023M |
| September 26, 2024 | -3.904M |
| September 25, 2024 | -3.990M |
| September 24, 2024 | -3.193M |
| September 23, 2024 | -3.136M |
| September 20, 2024 | -4.104M |
| September 19, 2024 | -3.848M |
| September 18, 2024 | -3.819M |
| September 17, 2024 | -4.189M |
| September 16, 2024 | -3.990M |
| September 13, 2024 | -3.933M |
| September 12, 2024 | -3.933M |
| September 11, 2024 | -4.018M |
| September 10, 2024 | -4.104M |
| September 09, 2024 | -4.132M |
| September 06, 2024 | -4.018M |
| September 05, 2024 | -3.762M |
| September 04, 2024 | -3.990M |
| September 03, 2024 | -3.819M |
| August 30, 2024 | -3.592M |
| August 29, 2024 | -3.62M |
| August 28, 2024 | -3.705M |
| August 27, 2024 | -3.819M |
| August 26, 2024 | -3.592M |
| August 23, 2024 | -4.047M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-35.75M
Minimum
Mar 14 2022
141.14M
Maximum
Feb 10 2021
6.639M
Average
-4.735M
Median
Apr 09 2024
Enterprise Value Benchmarks
| Agilent Technologies Inc | 40.48B |
| Seelos Therapeutics Inc | 10.27M |
| Cara Therapeutics Inc | -40.33M |
| Citius Pharmaceuticals Inc | 47.55M |
| NovaBay Pharmaceuticals Inc | 3.615M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.319M |
| Total Expenses (Quarterly) | 6.185M |
| EPS Diluted (Quarterly) | -1.70 |
| Earnings Yield | -486.2% |